A first-in-human study assessing the safety, pharmacokinetics, and pharmacodynamics of TU7710, a recombinant factor VIIa–transferrin fusion protein, in warfarin-pretreated healthy male participants

Journal of Thrombosis and Haemostasis 2026

View at publisher

Authors: Byungwook Kim, Jisoo Song, Jaegu Kang, Minsun Lee, Ji Hyun Noh, Heeyeon Jung, Kyung‐Sang Yu

DOI: 10.1016/j.jtha.2025.12.023

Cited by: 0

References: 19

Fields of Study & Subjects

Hemophilia Treatment and Research Platelet Disorders and Treatments Blood transfusion and management

References 19